Catia Traversari
Research
Pharmaceutical Science
Molmed S.p.A
Italy
Biography
Catia Traversari joined MolMed in January 2002. Prior to this date, she held the position of head of Cancer Immunotherapy and Gene Therapy in Genera Spa. She has over 15 years experience in tumor immunology and immunotherapy research. Catia was directly involved in the molecular cloning of the first human tumor antigen gene during her stage at the Ludwig Institute. She is the author of more than 70 publications and inventor of several of the company's core technologies. She joined the San Raffaele Scientific Institute in 1991 and was among the founding members of the Gene Therapy Programme. Previously, Catia Traversari served as Visiting Scientist at the Ludwig Institute for Cancer Research in Bruxelles and as research associate at the Istituto dei Tumori in Milan, one of the leading non-profit cancer research centres in Italy. Catia Traversari graduated in Biology at the University of Milan.
Research Interest
Immunotherapy and Immunology
